Law360 (February 15, 2019, 4:07 PM EST) -- Appraisal arbitrage is falling out of style as the reality of recent Delaware rulings sets in, with a new study showing the number of mergers facing shareholder challenges over deal price dropped meaningfully for the second year in a row.
A study from Cornerstone Research released Wednesday evaluates how appraisal litigation has evolved since a 2007 opinion in In re: Appraisal of Transkaryotic Therapies Inc. laid the groundwork for an investment strategy known as appraisal arbitrage. The strategy sees shareholders — largely hedge funds and private equity firms — buy into target companies with the goal of gaining a higher deal price...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!